HOME › DRUGS › RAVULIZUMAB
ACTIVE SUBSTANCE / INN

RAVULIZUMAB

Brand name(s): Ultomiris
EMA LISTED
AUTHORISED
Hemoglobinuria, Paroxysmal
ACTIVE SUBSTANCE
Ravulizumab
REGULATORS
EMA
SPONSORS / MAH
Alexion Europe SAS
TOTAL APPLICATIONS
1
EMA AUTHORISATIONS
PRODUCT NAMEHOLDERSTATUSDATEINDICATION
UltomirisAlexion Europe SASAuthorised02/07/2019Hemoglobinuria, Paroxysmal

FULL INTELLIGENCE ON RAVULIZUMAB

Patent cliffs, clinical trials, pipeline data, AI-enriched regulatory signals — free on PharmaSignal.

OPEN PLATFORM →